marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
"to be honest, that was what i had almost expected," she said..
it also provides 85 per cent accurate prediction results than current methods..
.
..
updated: may 18, 2018, 10.36 am ist